Buscar
29/10/2024
Incidence, Predictors, and Clinical Impact of Early Safety After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria
Avvedimento, M, Gonzálvez-García, A, Cepas-Guillen, PL, Ternacle, J, Urena, M, Alperi, A, Fernández, GV, Franco, LN, Vilalta, V, Esposito, G, Campelo-Parada, F, Indolfi, C, Del Trigo, M, Munoz-Garcia, A, Melon, NMM, Asmarats, L, Regueiro, A, del Val, D, Auffret, V, Beaumont, E, Rodes-Cabau, J. Incidence, Predictors, and Clinical Impact of Early Safety After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024; 84(18)DOI:. PMID:. IF:22.300(Q1/1D).
29/10/2024
Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement
Avvedimento, M, Cepas, P, Ternacle, J, Urena, M, Alperi, A, Fernandez, GV, Franco, LN, Vilalta, V, Esposito, G, Campelo-Parada, F, Indolfi, C, Del Trigo, M, Munoz-Garcia, A, Melon, NMM, Asmarats, L, Regueiro, A, del Val, D, Auffret, V, Cote, M, Mehran, R, Capodanno, D, Garot, P, Rodes-Cabau, J. Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024; 84(18)DOI:. PMID:. IF:22.300(Q1/1D).
29/10/2024
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.
Iacoboni G, Navarro V, Sesques P, Rejeski K, Bastos-Oreiro M, Serpenti F, Martin Lopez AA, Iraola-Truchuelo J, Delgado J, Perez A, Guerreiro M, Caballero AC, Martinez-Cibrian N, Luzardo Henriquez H, Sanchez Pina JM, Sancho JM, Ghesquieres H, Mussetti A, Lopez Corral L, Hernani R, Reguera JL, Sureda A, Bosch F, Martin Garcia-Sancho A, Kwon M, Subklewe M, Kuhnl A, Bachy E, Barba P, Villacampa G, Abrisqueta P. Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.. Journal of Hematology & Oncology. 2024; 17(1)DOI:10.1186/s13045-024-01608-8. PMID:39468591. IF:(Q/D).
28/10/2024
Hereditary transthyretin amyloidosis caused by Val142Ile variant in Spain: phenotypic characteristics, geographic distribution and population frequency
Seminario, FD, Aventin, BP, Eiros, R, Freire, JL, Sevilla, T, Carbayo, A, Llongueras, P, Garcia-Alvarez, A, Ripoll-Vera, T, Macias, R, Vilches, S, Ruiz-Bustillo, S, Achaga, XA, Ordas, JG, Gonzalez-Costello, J. Hereditary transthyretin amyloidosis caused by Val142Ile variant in Spain: phenotypic characteristics, geographic distribution and population frequency. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.2073. PMID:. IF:35.600(Q1/1D).
28/10/2024
Effects of exercise referral schemes enhanced with behavioural self-management strategies on functional capacity and self-reported disability in community-dwelling older adults. Secondary results from the SITLESS multi-country, three-armed randomized controlled trial
Olsen, PO, Tully, MA, Cruz, BD, Giné-Garriga, M, Coll-Planas, L, Roqué, M, Rothenbacher, D, Dallmeier, D, Sansano-Nadal, O, Blackburn, NE, Wilson, JJ, Skjodt, M, Caserotti, P. Effects of exercise referral schemes enhanced with behavioural self-management strategies on functional capacity and self-reported disability in community-dwelling older adults. Secondary results from the SITLESS multi-country, three-armed randomized controlled trial. AGE AND AGEING. 2024; 53(10)DOI:10.1093/ageing/afae225. PMID:39468725. IF:7.100(Q1/1D).
28/10/2024
Current application and results of the combined use of intravascular lithotripsy and rotational atherectomy for the treatment of calcified coronary lesions
Van Oort, M, Al Amri,, Bingen, BO, Oliveri, F, Del Olmo, VV, Jurado-Roman, A, Cordoba-Soriano, JG, Rumiz-Gonzalez, E, Fernandez-Peregrina, E, Van Der Kley, F, Jukema, JW, Montero-Cabezas, JM. Current application and results of the combined use of intravascular lithotripsy and rotational atherectomy for the treatment of calcified coronary lesions. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.2404. PMID:. IF:35.600(Q1/1D).
28/10/2024
The hemodynamic classification system for hemodynamic-related adverse events in left ventricular assist device patients
Gallone, G, Baldetti, L, Konicoff, M, Ibero, J, Maestro-Benedicto, A, Morley-Smith, A, Vela, MM, Fiorelli, F, Frea, S, Vandenbriele, C, Panoulas,, Loforte, A, De Ferrari, GM, Saez, DG, Gil, FR. The hemodynamic classification system for hemodynamic-related adverse events in left ventricular assist device patients. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.1118. PMID:. IF:35.600(Q1/1D).
28/10/2024
Concomitant cardiac arrest on cardiogenic shock patients. Differences in clinical profile and outcomes with non-cardiac arrest patients. The Shock CAT Study
Garcia-Garcia, C, Casquete, D, El Ouaddi, N, Andrea, R, Sanz, E, Sanchez-Salado, JC, Aboal, J, Pastor, P, Buera,, Sionis, A, Lopez, T, Rodriguez, J, Ariza, A, Baneras, J, Rueda, F. Concomitant cardiac arrest on cardiogenic shock patients. Differences in clinical profile and outcomes with non-cardiac arrest patients. The Shock CAT Study. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.1701. PMID:. IF:35.600(Q1/1D).
28/10/2024
Characterization of tricuspid regurgitation in patients following left bundle branch pacing
Fernandez, MA, Santos, JFQ, Gallego, IM, Alonso-Martin, C, Petracca, RL, Li, CH. Characterization of tricuspid regurgitation in patients following left bundle branch pacing. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.1946. PMID:. IF:35.600(Q1/1D).
28/10/2024
Collagen VI and endotrophin: potential extracellular matrix targets to attenuate adverse cardiac remodeling post-infarction
Garcia-Arguinzonis, M, Vilahur, G, De Santisteban,, Badimon, L, Padro, T. Collagen VI and endotrophin: potential extracellular matrix targets to attenuate adverse cardiac remodeling post-infarction. EUROPEAN HEART JOURNAL. 2024; 45DOI:10.1093/eurheartj/ehae666.3724. PMID:. IF:35.600(Q1/1D).
28/10/2024
International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy
Zeng, GH, Zhong, W, Mazzon, G, Zhu, W, Lahme, S, Khadgi, S, Desai, J, Agrawal, M, Schulsinger, D, Gupta, M, Montanari, E, Martinez, JML, Almousawi, S, Malonzo, VEF, Sriprasad, S, Arumuham, V, Ferretti, S, Kamal, W, Xu, KW, Cheng, F, Gao, XF, Cheng, JW, Somani, B, Duvdevani, M, Git, KA, Seitz, C, Bernardo, N, Ibrahim, TAA, Aquino, A, Yasui, T, Fiori, C, Knoll, T, Papatsoris, A, Gadzhiev, N, Zhanbyrbekuly, U, Angerri, O, Ramos, HL, Saltirov, I, Moussa, M, Giusti, G, Vicentini, F, Suarez, EB, Pearle, M, Preminger, GM, Wu, QH, Durutovic, O, Ghani, K, Maroccolo, M, Brehmer, M, Osther, PJ, Zawadzki, M, Tursunkulov, A, Kytaibekovich, MN, Abuvohidov, AA, Lara, CAR, Noori, Z, Zanetti, SP, Shrestha, S, de la Rosette, J, Denstedt, J, Ye, ZQ, Sarica, K, Choong, S. International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy. Military Medical Research. 2024; 11(1)DOI:10.1186/s40779-024-00562-3. PMID:39465407. IF:22.900(Q1/1D).
25/10/2024
Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis
Martinez-Molina, C, Tey, JMG, Ruiz-Ramos, J, Feliu, A, Puig-Campmany, M, Vidal, S, Corominas, H. Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis. MEDICINA CLINICA. 2024; 163(8)DOI:10.1016/j.medcli.2024.05.007. PMID:39003114. IF:2.100(Q2/3D).
25/10/2024
Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathy
Michael, MR, Wieske, L, Allen, JA, Lunn, MP, Doppler, K, Tan, CY, Koike, H, Markvardsen, LK, Kapoor, M, Hsieh, ST, Nobile-Orazio, E, Jacobs, BC, Rajabally, YA, Basta, I, Ripellino, P, Querol, L, Eftimov, F. Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathy. BMC Neurology. 2024; 24(1)DOI:10.1186/s12883-024-03903-w. PMID:39455929. IF:2.200(Q3/6D).
23/10/2024
Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model
Zarate-Tamames, B, Garin, N, Calvin-Lamas, M, Jornet, S, Martinez-Simon, JJ, Garcia-Gil, S, Garcia-Rebolledo, EM, Morillo-Verdugo, R. Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model. Frontiers in Pharmacology. 2024; 15DOI:10.3389/fphar.2024.1461473. PMID:39512818. IF:4.800(Q1/2D).
22/10/2024
Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach
Muiño, E, Carcel-Marquez, J, Llucia-Carol, L, Gallego-Fabrega, C, Cullell, N, Lledós, M, Martin-Campos, JM, Villatoro-Gonález, P, Sierra-Marcos, A, Ros-Castelló, V, Aguilera-Simón, A, Marti-Fabregas, J, Fernandez-Cadenas, I. Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach. NEUROLOGY. 2024; 103(8)DOI:10.1212/WNL.0000000000209666. PMID:39298701. IF:8.500(Q1/1D).
18/10/2024
The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning
Kleinbongard, P, Arriola, CG, Badimon, L, Crisostomo, V, Giricz, Z, Gyöngyösi, M, Heusch, G, Ibanez, B, Kiss, A, de Kleijn, DPV, Podesser, BK, Carracedo, RR, Rodríguez-Sinovas, A, Ruíz-Meana, M, Margallo, FMS, Vilahur, G, Zamorano, JL, Zaragoza, C, Ferdinandy, P, Hausenloy, DJ. The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning. BASIC RESEARCH IN CARDIOLOGY. 2024; 119(6)DOI:10.1007/s00395-024-01083-9. PMID:39422732. IF:8.000(Q1/1D).
18/10/2024
Familial aortic aneurysm: a case presentation
Codes-Méndez, H, Moya-Alvarado, P, Corominas, H. Familial aortic aneurysm: a case presentation. MEDICINA CLINICA. 2024; 163(7)DOI:. PMID:38926034. IF:2.100(Q2/3D).
18/10/2024
Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support
Marín-Cerezuela, M, Martín-Latorre, R, Frasquet, J, Ruiz-Ramos, J, Garcia-Contreras, S, Gordón, M, Broch, MJ, Castellanos-Ortega, A, Ramirez, P. Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support. CRITICAL CARE. 2024; 28(1)DOI:10.1186/s13054-024-05126-4. PMID:39425201. IF:9.300(Q1/1D).
17/10/2024
Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression
Monceau, A, Nath, RG, Suárez-Calvet, X, Musumeci, O, Toscano, A, Kierdaszuk, B, Kostera-Pruszczyk, A, Domínguez-González, C, Hernández-Lain, A, Paradas, C, Rivas, E, Papadimas, G, Papadopoulos, C, Chrysanthou-Piterou, M, Gallardo, E, Olivé, M, Lilleker, J, Roberts, ME, Marchese, D, Lunazzi, G, Heyn, H, Fernández-Simón, E, Villalobos, E, Clark, J, Katsikis, P, Collins, C, Mehra, P, Laidler, Z, Vincent, A, Tasca, G, Marini-Bettolo, C, Guglieri, M, Straub, V, Raben, N, Díaz-Manera, J. Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression. BRAIN. 2024; DOI:10.1093/brain/awae249. PMID:39045638. IF:11.700(Q1/1D).
16/10/2024
New COST Action 'EUropean network to tackle METAbolic alterations in HEART failure' (EU-METAHEART)
Maack, C, Vilahur, G, Ruiz-Meana, M, Hausenloy, D. New COST Action 'EUropean network to tackle METAbolic alterations in HEART failure' (EU-METAHEART). EUROPEAN HEART JOURNAL. 2024; 45(42)DOI:10.1093/eurheartj/ehae457. PMID:39412117. IF:35.600(Q1/1D).
15/10/2024
Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study
Blasco-Turrión, S, Crespo-Leiro, MG, Trenado, VD, Hion, PL, Molina, BD, Roura, G, Alvarez-Osorio, MP, Gómez-bueno, M, Bautista, CO, Diaz, JF, Bravo, IPG, Moreno, R, Sarnago-Cebada, F, González, NS, Hernandez, JM, del Blanco, BG, Farrero, M, Nadal, RO, Martin, P, de la Fuente, L, Sanz-Sánchez, J, Pérez, SM, Fernández, VA, Hospital, JAG, Granados, AL, Couto-Mallon, D, Espinosa, M, Sousa, DR, Zatarain-Nicolás, E, Aizpurua, DA, Vilella, RL, Roman, JAS, Amat-Santos, IJ. Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2024; 413DOI:10.1016/j.ijcard.2024.132340. PMID:38992809. IF:3.200(Q2/3D).
10/10/2024
The expression of VDACs and Bcl2 family genes in pituitary adenomas: clinical correlations and postsurgical outcomes
Facundo, AN, Magalhaes, M, Nascimento, GC, Azulay, RS, Santos, RM, Freitas, LA, Nascimento, AGPAC, Rodrigues, VP, Santos, WC, Beckman, AMGS, Abreu, JMF, Silva, RP, Carneiro, EL, Neto, CPO, da Costa, RMG, Corcoy, R, Mato, E, Faria, MS. The expression of VDACs and Bcl2 family genes in pituitary adenomas: clinical correlations and postsurgical outcomes. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1481050. PMID:39449743. IF:4.600(Q1/3D).
10/10/2024
The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone
Puig, L, Pérez-Hernández, M. The Importance of the Formulation in the Treatment of Psoriasis: The Case of Calcipotriol/Betamethasone. Dermatologic Therapy. 2024; 2024DOI:10.1155/2024/2351576. PMID:. IF:3.400(Q1/2D).
09/10/2024
"I drink less and that's no small matter": a qualitative descriptive study of a managed alcohol program evaluation in Barcelona
Velandia, DF, Rodriguez, EA, Albaina, AG, Clotas, C, Checa, MB, Rua, MIP, Gotsens, M. "I drink less and that's no small matter": a qualitative descriptive study of a managed alcohol program evaluation in Barcelona. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE. 2024; 50(6)DOI:10.1080/00952990.2024.2404242. PMID:39374264. IF:2.600(Q2/4D).
07/10/2024
Trends of European School of Urology (ESU) training and resident education: an overview of 2 decades of EAU education programme
Somani, B, Gomez-Rivas, J, Oliveira, TRD, Veneziano, D, Brouwers, T, Herrmann, C, Sedelaar-Maaskant, J, N'Dow, J, Palou, J, Li, N, Nedbal, C, Biyani, CS, Cleynenbreugel, B, Liatsikos, E. Trends of European School of Urology (ESU) training and resident education: an overview of 2 decades of EAU education programme. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05274-w. PMID:39373741. IF:2.900(Q2/3D).
06/10/2024
Impact of COVID-19 infection on genitourinary cancer management. SOGUG-COVID-19: A spanish, multicenter, observational study
Vidal, N, Climent, MA, Pérez, S, Méndez-Vidal, MJ, Anguera, G, Salas, IM, Gallardo, E, Cuéllar-Rivas, MA, Molina-Cerrillo, J, Martín, A, Rodriguez-Vida, A, Casado, EA, Gonzalez, M, Domènech, M, Kareaga, MM, Calvo, OF, Guzmán, JCV, Estévez, SV, Gonzàlez-del-Alba, A, Puente, J. Impact of COVID-19 infection on genitourinary cancer management. SOGUG-COVID-19: A spanish, multicenter, observational study. Clinical & Translational Oncology. 2024; DOI:10.1007/s12094-024-03744-6. PMID:39369361. IF:2.500(Q3/6D).
05/10/2024
Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes
Malan-Müller, S, Vidal, R, O'Shea, E, Montero, E, Figuero, E, Zorrilla, I, de Diego-Adeliño, J, Cano, M, García-Portilla, MP, González-Pinto, A, Leza, JC. Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes. Translational Psychiatry. 2024; 14(1)DOI:10.1038/s41398-024-03122-4. PMID:39368974. IF:6.200(Q1/1D).
03/10/2024
First clinical evaluation of a flexible digital ureteroscope with direct in scope suctioning system (Pusen DISS 7.5Ch): prospective multicentric feasibility study
Nedbal, C, Yuen, SKK, Akram, M, Keller, EX, Martínez, BB, Philip, J, Emiliani, E, Li, JKM, Stracci, D, Gauhar, V, Castellani, D, Somani, BK. First clinical evaluation of a flexible digital ureteroscope with direct in scope suctioning system (Pusen DISS 7.5Ch): prospective multicentric feasibility study. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05275-9. PMID:39361036. IF:2.900(Q2/3D).
03/10/2024
Novel risk loci for COVID-19 hospitalization among admixed American populations.
Diz-de Almeida S, Cruz R, Luchessi AD, Lorenzo-Salazar JM, de Heredia ML, Quintela I, González-Montelongo R, Nogueira Silbiger V, Porras MS, Tenorio Castaño JA, Nevado J, Aguado JM, Aguilar C, Aguilera-Albesa S, Almadana V, Almoguera B, Alvarez N, Andreu-Bernabeu Á, Arana-Arri E, Arango C, Arranz MJ, Artiga MJ, Baptista-Rosas RC, Barreda-Sánchez M, Belhassen-Garcia M, Bezerra JF, Bezerra MAC, Boix-Palop L, Brion M, Brugada R, Bustos M, Calderón EJ, Carbonell C, Castano L, Castelao JE, Conde-Vicente R, Cordero-Lorenzana ML, Cortes-Sanchez JL, Corton M, Darnaude MT, De Martino-Rodríguez A, Del Campo-Pérez V, de Bustamante AD, Domínguez-Garrido E, Eirós R, Fariñas MC, Fernandez-Nestosa MJ, Fernández-Robelo U, Fernández-Rodríguez A, Fernández-Villa T, Gago-Dominguez M, Gil-Fournier B, Gómez-Arrue J, Álvarez BG, Bernaldo de Quirós FG, González-Neira A, González-Peñas J, Gutiérrez-Bautista JF, Herrero MJ, Herrero-Gonzalez A, Jimenez-Sousa MA, Lattig MC, Borja AL, Lopez-Rodriguez R, Mancebo E, Martín-López C, Martín V, Martinez-Nieto O, Martinez-Lopez I, Martinez-Resendez MF, Martinez-Perez A, Mazzeu JF, Macías EM, Minguez P, Cuerda VM, Oliveira SF, Ortega-Paino E, Parellada M, Paz-Artal E, Santos NPC, Pérez-Matute P, Perez P, Pérez-Tomás ME, Perucho T, Pinsach-Abuin M, Pita G, Pompa-Mera EN, Porras-Hurtado GL, Pujol A, León SR, Resino S, Fernandes MR, Rodríguez-Ruiz E, Rodriguez-Artalejo F, Rodriguez-Garcia JA, Ruiz-Cabello F, Ruiz-Hornillos J, Ryan P, Soria JM, Souto JC, Tamayo E, Tamayo-Velasco A, Taracido-Fernandez JC, Teper A, Torres-Tobar L, Urioste M, Valencia-Ramos J, Yáñez Z, Zarate R, de Rojas I, Ruiz A, Sánchez P, Real LM, SCOURGE Cohort Group, Guillen-Navarro E, Ayuso C, Parra E, Riancho JA, Rojas-Martinez A, Flores C, Lapunzina P, Carracedo Á. Novel risk loci for COVID-19 hospitalization among admixed American populations.. eLife. 2024; 13DOI:10.7554/eLife.93666. PMID:39361370. IF:(Q/D).
02/10/2024
Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies
Schwartzman, S, Puig, L, Cohen, AD, Khattri, S, Jossart, C, Diaz, C, Garrelts, A, Ngantcha, M, Eberhart, N, Eleftheriadi, A, Tangsirisap, N, Schuster, C, Gottlieb, AB. Treatment-emergent Candida infections in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis treated with ixekizumab: an integrated safety analysis of 25 clinical studies. Expert Opinion On Drug Safety. 2024; 23(10)DOI:10.1080/14740338.2024.2399092. PMID:39234767. IF:3.100(Q2/4D).
02/10/2024
Delphi consensus on oral anticoagulation management in special clinical situations in the cardiology setting
Doblas, JJG, García-Moll, X, Freire, RB, Juanatey, CG, Morillas, M, Muñoz, AV, Escobar, C. Delphi consensus on oral anticoagulation management in special clinical situations in the cardiology setting. Future Cardiology. 2024; 20(13)DOI:10.1080/14796678.2024.2343550. PMID:39439239. IF:(Q/D).
01/10/2024
Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?
Saposnik, G, Monreal, E, Medrano, N, García-Domínguez, JM, Querol, L, Meca-Lallana, JE, Landete, L, Salas, E, Meca-Lallana, V, García-Arcelay, E, Agüera-Morales, E, Martínez-Yélamos, S, Gómez-Ballesteros, R, Maurino, J, Villar, LM, Caminero, AB. Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?. Multiple Sclerosis and Related Disorders. 2024; 90DOI:10.1016/j.msard.2024.105838. PMID:39216454. IF:2.900(Q2/4D).
01/10/2024
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE) : a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Allen, JA, Lin, J, Basta, I, Dysgaard, T, Eggers, C, Guptill, J, Gwathmey, KG, Hewamadduma, C, Hofman, E, Hussain, YM, Kuwabara, S, Le Masson, G, Leypoldt, F, Chang, T, Lipowska, M, Lowe, M, Lauria, G, Querol, L, Simu, MA, Suresh, N, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA, van Doorn, PA. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE) : a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial. LANCET NEUROLOGY. 2024; 23(10)DOI:10.1016/S1474-4422(24)00309-0. PMID:39304241. IF:45.500(Q1/1D).
01/10/2024
MRI for the diagnosis of limb girdle muscular dystrophies
Bolano-Díaz, C, Verdú-Díaz, J, Díaz-Manera, J. MRI for the diagnosis of limb girdle muscular dystrophies. CURRENT OPINION IN NEUROLOGY. 2024; 37(5)DOI:10.1097/WCO.0000000000001305. PMID:39132784. IF:4.400(Q1/2D).
01/10/2024
Natural history of spinal muscular atrophy patients with 3 and 4 copies of SMN2 gene - data from the national Spanish registry (CUIDAME)
Gawinska, KA, García, MF, Osorio, AN, Paradas, C, Sotoca, J, Povedano, M, Moreno, A, Henao, M, Gil, C, Rojas, R, Caravaca, MG, Grimalt, M, Torron, RF, Jericó, I, Campos, OG, de Laguna, LTB, Hervás, D, Tizzano, E, Costa, JV. Natural history of spinal muscular atrophy patients with 3 and 4 copies of SMN2 gene - data from the national Spanish registry (CUIDAME). NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.461. PMID:. IF:2.800(Q2/5D).
01/10/2024
SnRNAseq analysis of muscle samples of patients with SMA reveals novel pathogenic pathways and open avenues for new therapeutic strategies
Collins, C, Gokul-Nath, R, Katsikis, P, Fernández-Simón, E, Villalobos, E, Monceau, A, Reza, M, Mehra, P, Laidler, Z, Clark, J, Rojas-García, R, Tasca, G, Marini-Bettolo, C, Diaz-Manera, J. SnRNAseq analysis of muscle samples of patients with SMA reveals novel pathogenic pathways and open avenues for new therapeutic strategies. NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.611. PMID:. IF:2.800(Q2/5D).
01/10/2024
The International Clinical Outcome Study for Dysferlinopathy II: validation of motor outcome measures in a new patient cohort
Hilsden, H, James, M, Dressman, HG, Rufibach, L, Day, J, Mendell, J, Torron, RF, Harms, M, Pestronk, A, Vissing, J, Desai, U, Yoshimura, M, Shin, J, Mozaffar, T, Stojkovic, T, Pegoraro, E, Rivas, JB, Olive, M, Paradas, C, Straub, V. The International Clinical Outcome Study for Dysferlinopathy II: validation of motor outcome measures in a new patient cohort. NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.276. PMID:. IF:2.800(Q2/5D).
01/10/2024
Spanish Pompe Registry: overview based on the 130 patients included
Marín, RM, Leiva, DR, Osorio, AN, Muelas, N, Domínguez, C, Marcos, IR, Paradas, C, Olivé, M, Matas, A, Caravaca, MG, Romero, MB, Mendoza, M, de León, J, Gutiérrez, A, Rabasa, M, Segovia, S, Manera, JD. Spanish Pompe Registry: overview based on the 130 patients included. NEUROMUSCULAR DISORDERS. 2024; 43DOI:10.1016/j.nmd.2024.07.732. PMID:. IF:2.800(Q2/5D).
01/10/2024
RNA sequencing as a diagnostic tool in a cohort of 54 undiagnosed patients with neuromuscular diseases
Segarra-Casas, A, Domínguez-González, C, Natera-De-Benito, D, Ortez, C, Nascimiento, A, Hernández-Laín, A, Kapetanovic, S, Rodríguez, M, González-Mera, L, Nedkova, V, Fernández-Torrón, R, López-de Munain, A, Jimenez-Mallebrera, C, Rodríguez-Santiago, B, Gallardo, E, Olivé, M, Gallano, P, González-Quereda, L. RNA sequencing as a diagnostic tool in a cohort of 54 undiagnosed patients with neuromuscular diseases. NEUROMUSCULAR DISORDERS. 2024; 43DOI:. PMID:. IF:2.800(Q2/5D).
01/10/2024
Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease
Herrero-Lorenzo, M, Pérez-Pérez, J, Escaramís, G, Martínez-Horta, S, Pérez-González, R, Rivas-Asensio, E, Kulisevsky, J, Gámez-Valero, A, Martí, E. Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease. Journal of Extracellular Vesicles. 2024; 13(10)DOI:10.1002/jev2.12522. PMID:39377487. IF:14.500(Q1/1D).